Frazier Life Sciences VIII, L.P. is a venture capital fund based in Seattle, Washington. According to its most recent Form D, filed Oct 29, 2015, it has sold $262,000,000 of interests to 46 investors since its first sale in Oct 2015. The minimum investment it accepts from an outside investor is $68,750. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Alan Frazier; Nathan Every; Frazier Management, L.L.C.
- Total raised
- $262,000,000Cumulative sales reported on Form D
- Investors
- 46
- First sale
- Oct 15, 2015
- Minimum investment
- $68,750
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Alan Frazier; Nathan Every; Frazier Management, L.L.C
- Latest Form D
- Oct 29, 2015
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Frazier Life Sciences VIII, L.P.
What is the minimum investment for Frazier Life Sciences VIII, L.P.?
According to its latest Form D, filed Oct 29, 2015, the minimum investment Frazier Life Sciences VIII, L.P. accepts from an outside investor is $68,750.
Who can invest in Frazier Life Sciences VIII, L.P.?
Frazier Life Sciences VIII, L.P. is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has Frazier Life Sciences VIII, L.P. raised?
Frazier Life Sciences VIII, L.P. reports $262,000,000 sold from 46 investors on its Form D filed Oct 29, 2015. This is cumulative sales since the offering began, not current assets or performance.
Where is Frazier Life Sciences VIII, L.P. based?
Frazier Life Sciences VIII, L.P. is based in Seattle, Washington.
When did Frazier Life Sciences VIII, L.P. launch?
Frazier Life Sciences VIII, L.P. reports its first sale in Oct 2015.
Size compared with every venture capital fund
Raised more than 100% of the 5,433 venture capital funds based in Washington, and more than 99% of all 14,865 that report sales.